GUNA-GERIATRICS

Active substance: QUINONE, BARIUM OXALOSUCCINATE, CORTICOTROPIN, ARNICA MONTANA, BARIUM CARBONATE, BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN, MALIC ACID, SUS SCROFA FRONTAL LOBE, SUS SCROFA ADRENAL GLAND, PORK LIVER, SUS SCROFA HYPOTHALAMUS, RINFABATE, LUTRELIN, MELATONIN, NEUROTROPHIN-3, NEUROTROPHIN-4, OXYTOCIN, PHENYLALANINE, LEAD, PYRUVIC ACID, THYROTROPIN ALFA, LEVOTHYROXINE

SOLUTION/ DROPS · QUINONE 3 [hp_X]/30mL, BARIUM OXALOSUCCINATE 3 [hp_X]/30mL, CORTICOTROPIN 6 [hp_X]/30mL, ARNICA MONTANA 6 [hp_X]/30mL, BARIUM CARBONATE 6 [hp_X]/30mL, BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN 4 [hp_C]/30mL, MALIC ACID 3 [hp_X]/30mL, SUS SCROFA FRONTAL LOBE 6 [hp_X]/30mL, SUS SCROFA ADRENAL GLAND 6 [hp_X]/30mL, PORK LIVER 6 [hp_X]/30mL, SUS SCROFA HYPOTHALAMUS 6 [hp_X]/30mL, RINFABATE 4 [hp_C]/30mL, LUTRELIN 6 [hp_X]/30mL, MELATONIN 4 [hp_C]/30mL, NEUROTROPHIN-3 4 [hp_C]/30mL, NEUROTROPHIN-4 4 [hp_C]/30mL, OXYTOCIN 6 [hp_X]/30mL, PHENYLALANINE 3 [hp_X]/30mL, LEAD 6 [hp_X]/30mL, PYRUVIC ACID 3 [hp_X]/30mL, THYROTROPIN ALFA 6 [hp_X]/30mL, LEVOTHYROXINE 6 [hp_X]/30mL

United StatesActive

Marketing holder: Guna spa

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC
Countries with the substance registered: 1

Composition

QUINONE · 3 [hp_X]/30mL
BARIUM OXALOSUCCINATE · 3 [hp_X]/30mL
CORTICOTROPIN · 6 [hp_X]/30mL
ARNICA MONTANA · 6 [hp_X]/30mL
BARIUM CARBONATE · 6 [hp_X]/30mL
BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN · 4 [hp_C]/30mL
MALIC ACID · 3 [hp_X]/30mL
SUS SCROFA FRONTAL LOBE · 6 [hp_X]/30mL
SUS SCROFA ADRENAL GLAND · 6 [hp_X]/30mL
PORK LIVER · 6 [hp_X]/30mL
SUS SCROFA HYPOTHALAMUS · 6 [hp_X]/30mL
RINFABATE · 4 [hp_C]/30mL
LUTRELIN · 6 [hp_X]/30mL
MELATONIN · 4 [hp_C]/30mL
NEUROTROPHIN-3 · 4 [hp_C]/30mL
NEUROTROPHIN-4 · 4 [hp_C]/30mL
OXYTOCIN · 6 [hp_X]/30mL
PHENYLALANINE · 3 [hp_X]/30mL
LEAD · 6 [hp_X]/30mL
PYRUVIC ACID · 3 [hp_X]/30mL
THYROTROPIN ALFA · 6 [hp_X]/30mL
LEVOTHYROXINE · 6 [hp_X]/30mL

Registration

Registration number: 17089-349
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.18 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.19 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.20 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source
ingredients.21 · openFDA NDC · 17089-349 · Verified 2026-10-09 · open in source